Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARIQUELI: Potentiation of Quetiapine Treatment in Bipolar 1 Nonresponders Patients With Lithium or Aripiprazole

NCT01710163 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT01710163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01710163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARIQUELI: Potentiation of Quetiapine Treatment in Bipolar 1 Nonresponders Patients With Lithium or Aripiprazole
Lead sponsor
University of Sao Paulo
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2012
Completion date
June 30, 2015
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder